课题基金 / 基金详情

Role of a psychiatric disease risk factor in synaptic function and gene transcription regulation

Role of a psychiatric disease risk factor in synaptic function and gene transcription regulation
精神疾病危险因素在突触功能和基因转录调控中的作用
批准号:
9983166
负责人:
HONGJUN SONG
金额:
$114.15万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
已结题
起止时间:
至 2022-05-31

项目摘要

项目成果

HONGJUN SONG的其他基金

相似基金

相关文献

中文摘要
翻译
项目3:精神疾病风险因子在突触功能和基因转录中的作用 调节 摘要 绝大多数精神障碍背后的遗传复杂性使得对这些疾病的研究 极具挑战性。许多与风险相关的基因已经被发现,但其生物学作用主要是 未知。结构和功能连接改变的神经发育失调被认为是 许多神经精神障碍和“突触疾病”是生物学上的主要假说。 精神分裂症和其他主要精神疾病的基础。然而,对其病理生理学知之甚少。 患者神经元中的突触,潜在的分子和细胞机制,以及精神疾病的程度 紊乱可能会分享这些机制。精神分裂症1(DISC1)是一种基因突变 与精神分裂症、双相情感障碍和其他主要精神疾病的风险增加有关 精神错乱。大量动物研究表明,DISC1影响多个神经发育 过程,包括突触的形成。对重大精神疾病中突触功能障碍的认识 需要直接研究来自这些患者的人类神经元的突触特性 精神错乱。对患者体细胞进行重新编程使其能够重现正常和病态人类 特定条件下的组织发育特性和一种识别细胞过程的新方法 潜在的复杂的人类疾病,这可能导致基于机制的药物发现。一种罕见的基因突变 发现DISC1基因C末端的4个碱基对移码缺失与主要 一个较小的美国家庭中的精神障碍(H系)。目前的项目是建立在我们最初的基础上 结果显示,来自带有DISC1突变的ipscs的前脑神经元显示出显著的突触 缺陷和rna-seq分析显示,大量与 患者神经元的突触功能和精神障碍。利用特发性骨髓间充质干细胞的最新研究 精神分裂症患者也表现出类似的突触功能缺陷,并共享多个失调基因。 项目3将测试一个精神障碍风险基因调节突触功能的假设。 人类神经元通过生化和转录失调,这一核心缺陷也可能是 存在于特发性精神分裂症和双相患者衍生的神经元中。目标1将描述细胞 H家系和特发性精神分裂症患者大脑皮质神经元表型的研究 IPSCs。目的2将确定突变的DISC1在IPSC来源的星形胶质细胞中的作用。AIM 3将评估神经元 突变型DISC1亚型特异性对神经元发育、突触功能和转录的影响。每个人 AIM要求至少有一名学术和一名工业合作伙伴以及Janssen的核心B参与 旨在整合跨实验室的交叉验证,并建立可传播的协议 以供进一步验证。细胞表型将与NCRCRG中的其他IPSC品系进行比较,并将 通过SBMRI的Core C进一步开发成微型分析,用于未来的药物筛选。
英文摘要
Project 3: Role of a psychiatric disease risk factor in synaptic function and gene transcription regulation ABSTRACT Genetic complexity underlying the vast majority of mental disorders has made the study of these diseases exceptionally challenging. Many risk-associated genes have been identified but the biological role is largely unknown. Dysregulated neurodevelopment with altered structural and functional connectivity is believed to underlie many neuropsychiatric disorders and “a disease of synapses” is the major hypothesis for the biological basis of schizophrenia and other major psychiatric disorders. However, little is known about pathophysiology of synapses in patient neurons, underlying molecular and cellular mechanisms, and to what extent psychiatric disorders may share these mechanisms. Disrupted in Schizophrenia 1 (DISC1) is a gene in which mutations have been associated with increased risk for schizophrenia, bipolar disorder, and other major psychiatric disorders. A large number of animal studies have shown that DISC1 affects multiple neurodevelopmental processes, including synapse formation. Understanding synaptic dysfunction in major psychiatric disease requires direct investigation of synapse properties in human neurons derived from patients with these disorders. Reprogramming patient somatic cells enables recapitulation of normal and pathological human tissue developmental properties in defined conditions and a new way to identify the cellular processes underlying complex human diseases, which can lead to mechanism-based drug discovery. A rare mutation of a 4 base-pair frame-shift deletion at the C-terminus of DISC1 was discovered to co-segregate with major psychiatric disorders in a smaller American family (Pedigree H). The current project is built upon our initial results showing that forebrain neurons derived from iPSCs with the DISC1 mutation exhibit significant synaptic defects and RNA-seq analysis showed significant dysregulation of a large number of neuronal genes related to synaptic function and psychiatric disorders in patient neurons. Recent studies using iPSCs from idiopathic schizophrenia patients also showed similar defects in synaptic function and share multiple dysregulated genes. Project 3 will test the hypothesis that a psychiatric disorder risk gene modulates synaptic function of human neurons via biochemical and transcriptional dysregulation, a core defect that may also be present in idiopathic schizophrenia and bipolar patient-derived neurons. Aim 1 will characterize cellular phenotypes of human cortical neurons differentiated from Pedigree H and idiopathic schizophrenia patient iPSCs. Aim 2 will determine the role of mutant DISC1 in iPSC-derived astrocytes. Aim 3 will evaluate neuronal subtype specificity of mutant DISC1 effects on neuronal development, synaptic function and transcription. Each aim requires the involvement of at least one academic and one industrial partner as well as Core B at Janssen and is designed to incorporate cross-validation across labs and establish protocols that can be disseminated for further validation. Cellular phenotypes will be compared to other iPSC lines in the NCRCRG and will be further developed into miniaturized assays via Core C at SBMRI for future drug screens.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Defining causal roles of genomic variants on gene regulatory networks with spatiotemporally-resolved single-cell multiomics
  • 批准号:
    10630265
  • 项目类别:
  • 资助金额:
    $121.0万
  • 财政年份:
    2021
  • 负责人:
    HONGJUN SONG
  • 依托单位:
Continuous neurogenesis in the mammalian hippocampus
  • 批准号:
    10665972
  • 项目类别:
  • 资助金额:
    $16.25万
  • 财政年份:
    2020
  • 负责人:
    HONGJUN SONG
  • 依托单位:
Continuous Neurogenesis in the Mammalian Hippocampus
  • 批准号:
    10402870
  • 项目类别:
  • 资助金额:
    $94.09万
  • 财政年份:
    2020
  • 负责人:
    HONGJUN SONG
  • 依托单位:
Continuous Neurogenesis in the Mammalian Hippocampus
  • 批准号:
    10152685
  • 项目类别:
  • 资助金额:
    $94.04万
  • 财政年份:
    2020
  • 负责人:
    HONGJUN SONG
  • 依托单位:
海外基金